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Abstract
Heart and Skeletal Muscle Inflammation (HSMI), recently associated with a novel Atlantic salmon reovirus (ASRV), is currently
one of the most prevalent inflammatory diseases in commercial Atlantic salmon farms in Norway. Mortality varies from low
to 20%, but morbidity can be very high, reducing growth performance and causing considerable financial impact. Clinical
symptoms, including myocarditis, myocardial and red skeletal muscle necrosis, correlate with the intensity of the
inflammatory response. In the present study, the effects of two functional feeds (FF1 and FF2) were compared to a standard
commercial reference feed (ST) in Atlantic salmon subjected to an ASRV challenge. The functional feeds had reduced levels
of total lipid and digestible energy, and different levels and proportions of long-chain polyunsaturated fatty acids (LC-PUFA).
The objective was to determine whether these feeds could provide effective protection by decreasing the inflammatory
response associated with HSMI. Histopathology, viral load, fatty acid composition and gene expression of heart tissue were
assessed over a period of 16 weeks post-infection with ASRV. The viral load and histopathology scores in heart tissue in
response to ASRV infection were reduced in fish fed both functional feeds, with FF1 showing the greatest effect. Microarray
hierarchical cluster analysis showed that the functional feeds greatly affected expression of inflammation/immune related
genes over the course of the ASRV infection. Viral load correlated with up-regulation of pro-inflammatory genes at the early-
mid stages of infection in fish fed the ST diet. Expression of inflammatory genes 16-weeks after ASRV challenge reflected the
difference in efficacy between the functional feeds, with fish fed FF1 showing lower expression. Thus, severity of the lesions
in heart tissue correlated with the intensity of the innate immune response and was associated with tissue fatty acid
compositions. The present study demonstrated that dietary modulation through clinical nutrition had major influences on
the development and severity of the response to ASRV infection in salmon. Thus, HSMI was reduced in fish fed the
functional feeds, particularly FF1. The modulation of gene expression between fish fed the different feeds provided further
insight into the molecular mechanisms and progression of the inflammatory and immune responses to ASRV infection in
salmon.
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Introduction
Heart and Skeletal Muscle Inflammation (HSMI) was first
diagnosed in 1999 [1] and has been associated with a novel piscine
reovirus [2] recently defined as Atlantic salmon reovirus (ASRV)
[3]. It is currently one of the most prevalent inflammatory diseases
in commercial Atlantic salmon farms in Norway, with over 600 sites
affected since 2003. Isolated cases have also been detected in the
United Kingdom [4]. Mortality associated with HSMI varies
between outbreaks; from insignificant to 20% of stock [5], but
morbidity can be very high, significantly reducing growth perfor-
mance, increasing feed conversion ratio, and causing considerable
financial impact. Clinical symptoms include aberrant swimming
behaviour (lethargic fish) believed to be associated with reduced
heart function and poor circulation. Histopathologically, heart and
red skeletal muscle appear to be the main organs affected showing
severe inflammation. Epi-, endo-, and myocarditis and myocardial
necrosis, as well as necrosis of red skeletal muscle are characteristic
of the disease, although liver damage is also found [5]. These clinical
symptoms are believed to correlate with the intensity of the
inflammatory response, so factors modulating inflammation might
influence the clinical manifestation of this disease.
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One strategy to potentially control outbreaks of HSMI, or
reduce the severity of the disease, is through the application of
clinical nutrition and functional feeds. The concept of clinical
nutrition and functional foods is well known in human nutrition.
Functional foods are defined as foods that contain a component
(whether a nutrient or not) that could be beneficial for the state of
well-being and health, or reduce the risk of a disease, beyond the
basic nutritional requirement [6]. Therefore, dietary supplemen-
tation is now a common complementary therapy, not only to
improve the general health status of the population, but also for
the management of common inflammatory diseases such as
rheumatoid arthritis [7] or coronary diseases [8]. This type of
approach is also becoming increasingly popular in aquaculture as
it could potentially result in great economical savings in terms of
increased productivity and lower costs of disease treatment/
management [9–11]. At the current time HSMI vaccines are still
under development and efficacy of other commercially available
viral vaccines may be variable [12]. Clinical nutrition offers a
valuable additional tool to reduce the impact of viral diseases.
There are many additives used in aquaculture diets including
probiotics, prebiotics, immunostimulants, vitamins and nucleo-
tides, which are included in commercial feeds to increase growth
and feed conversion efficiency, as well as having positive effects on
the fish immune system [11]. The replacement of fishmeal with
plant-derived protein sources can lead to changes in gut flora and
physiology, probably due to higher contents of non-digestible
fibrous components, and increased levels of anti-nutritional
factors, whose negative effects can be ameliorated by the additives
mentioned above [13]. Another concern in recent years has been
the replacement of dietary fish oil (FO) by vegetable oils (VO).
This is a consequence of generally decreasing wild fisheries
worldwide that, not only supply a declining proportion of fish for
direct human consumption, but also, paradoxically, could
constrain the growth of aquaculture due to reduced availability
of fishmeal and FO, required for the manufacture of aqua feeds
[14,15].
It is well known that dietary polyunsaturated fatty acids (PUFA)
can influence the immune response. Arachidonic acid (ARA,
20:4n-6), eicosapentaenoic acid (EPA, 20:5n-3) and docosahex-
aenoic acid (DHA, 22:6n-3), derived from cell membrane
phospholipids, are precursors of eicosanoids, resolvins and
protectins, which modulate leukocyte function and thereby
influence production of inflammatory cytokines and adhesion
molecules [16]. The eicosanoids derived from ARA promote pro-
inflammatory responses, whereas those derived from EPA and
DHA either produce a reduced inflammatory response or actually
resolve (terminate) the inflammatory response [17]. Dietary
supplementation with n-3 long-chain (LC) PUFA, EPA and
DHA, protects against cardiovascular diseases, and may also be
beneficial for some common inflammatory disorders in humans
[18]. Studies have demonstrated that these LC-PUFA have the
same role in immunomodulation in fish, and this has been an
important concern particularly in recent years with increased
energy (lipid) content of commercial diets and the aforementioned
replacement of dietary FO by VO, which are devoid of LC-PUFA,
but rich in n-6 PUFA [19,20]. Such dietary replacement decreases
the n-3/n-6 LC-PUFA ratio in tissues, potentially promoting the
synthesis of pro-inflammatory eicosanoids, and several studies
have examined whether this might affect disease resistance in
farmed animals [21,22]. In general, fish fed diets with a high level
of VO inclusion may be less resistant to infection and prone to
increased severity of inflammatory responses due to the reduced n-
3/n-6 PUFA ratio. Influence of dietary lipid content has also been
investigated. It was reported that diets with higher lipid content
may be associated with increased mortality and muscle lesions in
Atlantic salmon suffering from pancreas disease, a common viral
infection in salmon farming [10].
Oligonucleotide microarray analysis of tissue transcriptomes has
become an increasingly popular tool in fish nutritional studies but,
in addition, has also provided a global overview of the cellular and
molecular events activated upon viral infections, and genome-wide
changes after vaccination [23] or infection [24]. Host genes and
immune responses induced after infection with different viral
diseases of salmon such as infectious salmon anaemia (ISA) [25,26]
and infectious hematopoietic necrosis (IHN) virus [27] have been
characterized using transcriptomic analysis. Krasnov et al. [28]
identified virus responsive genes (VRG) in different viral diseases
including HSMI, but there are no further descriptions of the
immune response specifically related to this disease, such as the
expression of host genes after infection with ASRV.
The aim of the present study was to investigate the application
of a clinical nutrition strategy in Atlantic salmon subjected to
experimental ASRV challenge, through the use of two potential
functional feed formulations in comparison to a standard
commercial feed. The standard reference diet (ST diet) contained
31% lipid derived from marine (FO and fishmeal) and terrestrial
(rapeseed oil) sources. The functional feeds had reduced energy
levels through lower lipid (18%), and increased levels of EPA, and
increased n-3/n-6 PUFA and EPA/ARA ratios, which were
achieved by increased protein (fishmeal and krill meal) (FF1 diet),
or krill meal plus krill oil (FF2 diet). Krill products, especially krill
oil, are good sources of EPA and DHA in a phospholipid form
[29]. Dietary krill oil increased incorporation of EPA and DHA
into heart phospholipids in rats [30], and decreased the
inflammatory process associated with chronic diseases such as
rheumatoid arthritis in humans [31]. The incorporation of anti-
inflammatory LC-PUFA into heart, the main organ affected by
the disease, and head kidney (the main immune organ) was
assessed. In addition to histological evaluation, gene expression in
heart tissue was monitored by microarray analysis over a period of
16 weeks after infection with ASRV, and viral load assessed over
the later collections times (.10 weeks post challenge). Therefore,
this was a nutritional study specifically designed to determine
whether functional feeds could ameliorate the pathological effects
of the ASRV infection, and to identify pathways/mechanisms
underpinning the dietary effects in order to improve feed
formulations.
Results
1. The viral load and histopathology scores in heart tissue
in response to ASRV infection were reduced in fish fed
both functional feeds, with the most significant effects
observed in fish fed FF1
We first used RT-qPCR to compare the viral load observed in
heart tissue between the different dietary groups at later stages of
the infection, when the inflammatory response typical of HSMI
appeared in heart tissue in challenged fish, i.e. 12- to 16-weeks
post-challenge [1,5]. We found there was considerably higher viral
load at 12-weeks post-challenge in fish consuming the ST diet
compared with fish fed the two functional feeds (Fig. 1). Fish fed
the ST diet showed 260-fold greater viral load (p,0.05) than fish
fed the FF1 diet. Compared to the FF2 diet, relative levels were
25-fold higher in ST fish but, due to the high variability between
individuals, this difference was not significant. The pathophysio-
logical response to the infection characterised histologically by
infiltration of lymphocytes and macrophages in heart tissue,
reflected the pattern of viral load as had been shown earlier [3].
Functional Feeds Reduce HSMI Heart Inflammation
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There was no infiltration of inflammatory or immune cells in heart
tissue in any dietary group at 8-weeks post-challenge (Fig. 2).
However, from 10-weeks onwards, the histopathology scores
showed that the levels of cardiac inflammation were much higher
at all-time points in fish consuming the ST diet compared to fish
fed the functional feeds (FF1 and FF2 groups). In addition, the fish
fed diet FF1 showed the significantly lowest level of cardiac
inflammation when the data were combined across all time points
(Fig. 2).
2. Fatty acid compositions of heart and head kidney
tissues were associated with the severity of the
inflammatory response/disease
The fact that diets modulated the viral load and inflammatory
scores to the extent observed was surprising and, based on the
difference in fatty acid composition between diets, we first
examined the fatty acid profiles of heart and head kidney tissues
(Tables 1 and 2). Generally, the fatty acid composition of these
organs reflected the fatty acid composition of the diets fed to the
fish (Table 3) in a similar manner to that observed in previous
studies that investigated effects of diet on fatty acid profiles of heart
[32] and head kidney [33]. The proportion of EPA and the EPA/
ARA ratio were significantly higher in heart tissue of fish
consuming the functional feeds (Table 1). In general, the overall
fatty acid profile of heart tissue changed relatively little during the
time-course of the infection. In contrast, we found that the fatty
acid profile of head kidney tissue showed more significant
differences between the three dietary groups, and the proportions
of most of the LC-PUFA related to the immune response changed
during the course of the infection (Table 2). For instance, the
proportions of total n-3PUFA and DHA increased, and those of
ARA and monoenes decreased, over the course of the infection.
The proportion of EPA also decreased in fish fed the ST diet over
the course of the infection but, in contrast, EPA increased in fish
fed the functional feeds between weeks 8 and 16 (Table 2).
Previous studies have shown that levels of EPA, ARA and DHA
could determine the intensity of inflammatory response, with EPA
and DHA being anti-inflammatory fatty acids and ARA pro-
inflammatory [34]. In concert with this finding, our results showed
that tissue levels of EPA and DHA and the EPA/ARA ratios were
significantly higher in fish fed the functional feeds than in fish fed
the ST diet, which was consistent with the reduced inflammatory
response in heart tissue in these groups (Fig. 2).
3. Microarray hierarchical cluster analysis showed that
the functional feeds greatly affected expression of
immune related genes over the course of the ASRV
infection
We then went on to profile the transcriptomes of the heart
tissue over time post challenge in an effort to fingerprint the
contrasting inflammatory responses observed in the different
diet groups. A hierarchical cluster analysis of heart tissue
transcriptomes was performed and the results indicated clearly
contrasting patterns of gene expression over the course of the
infection between different dietary treatments (Fig. 3). There
was a strong up-regulation (shown in red colour) of a group of
genes at 12-weeks post-challenge in fish consuming the ST diet.
The same group of genes was similarly strongly up-regulated at
16-weeks post-challenge in fish consuming the FF2 diet (Fig. 3,
outmost lane to the right). In both cases there was concomitant
down-regulation of another distinct group of genes. Based on
this initial analysis, Self-Organizing Map (SOM) cluster analysis
Figure 1. Viral load in heart tissue of the different dietary groups at 12- and 16-weeks post-challenge. Viral load was determined by
quantitative real-time PCR analysis of Atlantic salmon reovirus OH-2010 strain ALV726 inner capsid protein lambda-1/VP3 gene (HM453201). Results
are presented as normalised expression data (n = 6) relative to b-actin on a log scale (log10) with statistical analysis by Kruskal-Wallis test (non-
parametric).
doi:10.1371/journal.pone.0040266.g001
Figure 2. Average histoscores (± SEM) in the different dietary
treatment groups at 8-, 10-, 12-, 14- and 16-weeks post-
challenge. Significant differences between feed groups are indicated.
N = 10 to 20 per group. Samples were scored by marking on a visual
analog scale on the basis of criteria described previously by Mikalsen et
al. (3) (see Table S3). A maximum score of 6 can be achieved for
combined epicardial and myocardial changes. Scoring was carried out
with a double-blind format.
doi:10.1371/journal.pone.0040266.g002
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was performed to prepared two lists containing all up- and
down-regulated genes from cluster groups (identified by SOM)
showing these patterns of expression. The list of down-regulated
features contained a set of 378 genes related to various cellular,
biological and metabolic pathways including cell survival
processes, regulation of apoptosis, regulation of transcription
and general lipid metabolic processes (Table S1). In contrast,
the list of up-regulated features contained a set of 732 genes
primarily related to various aspects and stages of the immune
response, including both innate and adaptive immune system
responses (Table S2). To assist the interpretation of these data,
the genes of the up-regulated list were sorted by fold-change
comparing 8 weeks versus 16 weeks in fish fed the FF2 diet. All
the genes showing an increase in expression from 8 to 12 weeks
greater than or equal to 5-fold, along with a small number of
other highly relevant genes with a fold-change lower than 5,
were considered for more detailed discussion of the data. The
179 genes in this list (Table S2) were categorized according to
the specific pathways/processes to which they are commonly
associated. The effects of the dietary treatments on these
pathways were analyzed to provide both an overview of the
major impacts of the functional feeds and, in particular, to
discriminate differences in gene expression between the two
functional feeds underpinning their differential effects on
HSMI. The major findings are outlined in the ensuing
paragraphs.
Table 1. Total lipid fatty acid composition (percentage of total fatty acids) of heart from Atlantic salmon fed the different diets at
8- and 16- weeks post-infection with ASRV.
8 weeks 16 weeks TWO WAY ANOVA P-value
Fatty acid ST FF1 FF2 ST FF1 FF2 Diet Week Diet*Week
Saturated 25.48 64.17 27.22 61.92 28.45 61.45 22.33 60.90a 25.16 61.05b 27.07 61.01c 0.001 0.008 ns
Mono 26.48 68.25 21.69 64.19 26.74 69.68 35.32 67.35 26.58 67.44 24.97 66.90 ns ns ns
20:3n-6 0.32 60.07ab 0.38 60.06a 0.27 60.06b 0.28 60.02a 0.35 60.05b 0.30 60.03ab 0.005 ns ns
20:4n-6 1.87 60.76 1.95 60.44 1.40 60.56 1.10 60.37 1.45 60.42 1.53 60.39 ns ns ns
N-6 PUFA 8.36 61.11a 6.82 60.31b 6.00 60.43b 9.34 60.88a 7.30 60.65b 5.66 60.38c 0.000 ns ns
20:5n-3 6.21 61.96 8.67 61.31 6.98 62.19 4.53 61.27a 7.86 61.39b 7.19 61.21b 0.002 ns ns
22:6n-3 27.69 67.03 30.08 63.40 26.67 69.10 22.19 66.52 27.23 67.34 30.26 67.29 ns ns ns
N-3 PUFA 38.64 68.39 43.44 64.54 38.30 611.09 32.45 67.20 40.28 68.20 41.62 68.08 ns ns ns
PUFA 48.04 68.05 51.08 64.22 44.81 611.12 42.35 66.48 48.22 67.19 47.95 67.70 ns ns ns
EPA/ARA 3.49 60.65a 4.57 60.77ab 5.21 60.86b 4.19 60.40a 5.62 60.98b 4.83 60.76ab 0.000 ns ns
N-3/N-6 4.73 61.36 6.40 60.89 6.38 61.83 3.56 61.13a 5.62 61.54ab 7.46 61.84b 0.000 ns ns
Results are means 6 SD (n = 5).P-values of two-way ANOVA are presented for factors ‘diet’, ‘time’ and interaction between factors.
Values within a row at each time point with different superscript letters are significantly different as determined by one-way ANOVA.
ARA, arachidonic acid; EPA, eicosapentaenoic acid; ns, not significant (p.0.05); PUFA, polyunsaturated fatty acids.
doi:10.1371/journal.pone.0040266.t001
Table 2. Total lipid fatty acid composition (percentage of total fatty acids) of head kidney of Atlantic salmon 8- and 16-weeks post-
infection with ASRV.
8 weeks 16 weeks TWO WAY ANOVA P-value
Fatty acid ST FF1 FF2 ST FF1 FF2 Diet Week Diet*Week
Saturated 22.01 60.72a 25.13 61.26b 27.41 60.58c 21.84 60.50a 25.03 60.41b 28.15 60.67c 0.000 ns ns
Monounsaturated 41.76 62.01 40.24 64.18 38.85 63.44 40.44 63.63a 35.15 61.97b 30.38 63.19b 0.000 0.000 ns
20:3n-6 0.24 60.02 0.25 60.03 0.22 60.03 0.26 60.03ab 0.30 60.01a 0.24 60.03b 0.002 0.002 ns
20:4n-6 1.31 60.21 1.22 60.44 1.25 60.35 0.66 60.14a 0.82 60.08ab 0.88 60.12b ns 0.000 ns
N-6 PUFA 9.88 60.56a 7.91 60.33b 6.56 60.26c 9.82 60.60a 7.83 60.46b 5.51 60.21c 0.000 0.000 0.007
20:5n-3 4.73 60.57 5.78 61.33 5.81 61.18 3.72 60.67a 6.63 60.44b 6.71 60.80b 0.000 ns 0.027
22:6n-3 15.02 61.53 14.39 62.68 15.77 62.26 17.47 63.46a 18.26 62.68a 23.69 62.75b 0.014 0.000 ns
N-3 PUFA 25.79 61.81 25.79 63.93 26.52 63.30 27.42 63.76a 30.87 62.60ab 35.37 63.06b 0.022 0.000 ns
PUFA 36.23 61.78 34.63 64.04 33.74 63.44 37.72 63.15 39.82 62.07 41.47 62.88 ns 0.000 ns
EPA/ARA 3.65 60.44a 4.91 60.67b 4.75 60.46b 5.69 60.78a 8.12 60.91b 7.69 60.40b 0.000 0.000 ns
N-3/N-6 2.62 60.26a 3.25 60.41b 4.03 60.38c 2.82 60.52a 3.97 60.56b 6.44 60.76c 0.000 0.000 0.001
Results are means 6 SD (n = 5). P-values of two-way ANOVA are presented for factors ‘diet’, ‘time’ and interaction between both factors. Values within a row with
different superscript letters are significantly different as determined by one way ANOVA. ARA, arachidonic acid; EPA, eicosapentaenoic acid; ns, not significant (p.0.05);
PUFA, polyunsaturated fatty acids.
doi:10.1371/journal.pone.0040266.t002
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4. Viral load correlated with up-regulation of pro-
inflammatory genes at the early-mid stages of the
infection in fish fed the ST diet
The heat map in Fig. 3 clearly indicated that timing of the
immune response was affected by the functional feeds and that the
ST diet at 12 weeks stands out compared to the other groups/time
points. As mentioned above, viral load was highest in heart tissue
of the ST diet (2566higher than FF1) at 12-weeks post-challenge
(Fig. 1), which was reflected in the strong up-regulation of genes
associated with viral entry and infection in ST-fed fish at that time,
(shown as down-regulated in functional diets relative to ST diet in
Table 4, Fig. S1A). As would be expected, the expression of genes
associated with the different pathways of the innate immune
response (see below) was considerably up-regulated at 12-weeks
post-challenge in fish fed the ST diet (Table 5 and 6; Fig. S1B and
C), particularly those involved in the interferon-inducible response
(Table 6; Fig. S1C), the natural killer cells response and apoptosis
(Table 7). Responses that fingerprint the cellular adaptive immune
response, were in general of lower magnitude, but also markedly
up regulated in the ST compared to the FF1 diet group, while
lesser so compared to the FF2 diet group (Table 8). Fish in the ST
diet group mount a strong, early response biased towards pro-
inflammatory and early adaptive responses.
5. Contrasting inflammatory gene expression in fish fed
the two functional feeds at 16-weeks after ASRV
challenge
Sixteen weeks after challenge, the replication of the viral load
had increased in fish consuming both functional feeds (Fig. 1). At
this time they also had a similar pattern of expression of immune
response genes (Tables 5,6,7,8,9), although the up-regulation was
greater in fish fed the FF2 diet compared with those fed the FF1
diet (Fig. S1B–F). Genes related to both the innate (Table 5; Fig.
Table 3. Total lipid fatty acid composition (percentage of
total fatty acids) and lipid class composition (percentage of
total lipid) of the experimental diets.
Fatty acid ST FF1 FF2
Saturated 23.97 36.48 31.86
Monounsaturated 45.73 33.10 37.05
18:2n-6 10.73 7.11 5.30
20:3n-6 0.06 0.11 0.10
20:4n-6 0.36 0.48 0.54
n-6 PUFA 11.63 8.09 6.50
18:3n-3 4.62 2.35 1.55
20:5n-3 4.85 8.76 9.53
22:6n-3 6.09 5.98 9.03
n-3 PUFA 17.83 19.83 23.32
PUFA 30.31 30.42 31.09
EPA/ARA 13.67 18.16 17.75
N-3/N-6 1.53 2.45 3.59
Phospholipids 8.94 10.77 17.30
Triacylglycerols 65.39 53.47 52.45
% Lipid 24.52 13.71 13.35
ARA, Arachidonic acid; EPA, eicosapentaenoic acid; PUFA, polyunsaturated fatty
acids.
doi:10.1371/journal.pone.0040266.t003
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S1B) and adaptive immune responses (Tables 8 and 9; Fig. S1E
and F) were particularly highly expressed in fish fed the FF2 diet
compared with fish fed the FF1 diet. The expression of the MHC
class II gene was, however, higher in fish fed the FF1 diet than in
fish fed the FF2 diet and, in both groups, the expression of this
gene was much higher than in the fish fed the ST diet (Table 9).
Leukotriene B4 receptor and arachidonate 5-lipoxygenase (ALOX)
are directly related to the eicosanoid pathway and therefore the
expression of their genes is likely related to levels of ARA and
EPA. We found that both were up-regulated at 16-weeks in fish fed
both functional feeds and interestingly the fold-changes comparing
the expression of both genes between 8- and 16-weeks were twice
as high in fed the FF2 diet compared to fish fed the FF1 diet
(Table 10), which again concurs with the observed difference in
the inflammatory profile between the two diets.
6. Severity of the lesions observed in heart tissue
correlated with the intensity of the innate immune
response
The microarray data showed that increased expression of genes
related to the innate immune response correlated with higher
histopathology scores. In general, this correlation was most
obvious in fish fed the ST diet at 12 weeks post-challenge, with
higher expression of genes involved in pathways of the virus-
induced innate immune response. These included platelet basic
protein, IRF7 and barrier to auto integration factor (Table 5),
interferon-inducible Mx proteins, Vig-2, gig-2 and cholesterol 25-
hydrolase (Table 6), granzyme A, serum amyloid A5, interleukins
12 and 18 and genes related to apoptosis (Table 7), and
chemokines (Table 5 and 9) among others. Again, there was a
lower intensity of this immune response in fish fed both the
functional feeds, particularly FF1, which correlated with the lower
histopathology scores in this group.
7. Innate and adaptive immune responses
Activation of the innate immune response in fish leads to the
stimulation of different components of the adaptive immune
response [35,36]. Consistent with this, the data obtained in the
present study show that differential upregulation of innate
responses in the ST diet group at 12 weeks (Table 5, Fig. S1B)
coincide with high expression of adaptive immune response genes
at 12 weeks in the ST group (Table 9; Fig. S1F). Similarly FF1 and
particularly FF2 have higher upregulation of innate and adaptive
immune genes by 16 weeks (Table 5 and 9; Fig. S1B and F).
8. The microarray analyses data were fully validated by
RT-qPCR of selected genes
Validation of the microarray data was performed by
comparing the expression of 12 key genes showing both up-
and down-regulation with a range of fold-changes from 1.1 to
13.9, across all three feed comparisons, and at two time points
(12- and 16-weeks), providing a matrix of 72 comparisons.
Figure 3. Hierarchical clustering of expression profiles for 2581
genes from the significant interaction list of the 2-way ANOVA
analysis across the different dietary treatments over the time
course of the infection. Individual gene expression profiles are
plotted horizontally against vertical columns of each dietary group over
the different time-points. Up- and down-regulation of gene expression
with respect to a common reference (a pool of all the samples) are
represented in red and green, respectively. Colour intensity depends on
the value of the expression ratio.
doi:10.1371/journal.pone.0040266.g003
Table 4. Viral infection-related genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2) relative to the
standard diet during the course of the infection with ASRV.
Accession or 8 weeks 10 weeks 12 weeks 16 weeks
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2
Viral entry and Cellular transport
CD209 antigen-like protein d Ssa#STIR16806 21,4 21,6 21,2 +1,0 23,3 22,7 +1,3 +3,3
C-type lectin domain family 4 member e Ssa#STIR09786 21,4 21,2 21,4 +1,2 24,1 23,2 +1,5 +4,0
Kelch-like protein 6 DW579982 +1,2 +1,3 +1,3 +1,2 22,6 21,6 21,1 +3,1
CD209 antigen-like protein A Ssa#KSSb2272 21,4 21,5 +1,0 +1,3 23,3 22,7 +1,1 +2,7
Ecotropic viral integration site 2a Ssa#STIR14026 21,0 21,1 +1,2 +1,1 23,3 22,1 21,0 +2,4
Macrosialin precursor Ssa#KSS4521 21,3 21,5 +1,2 +1,2 24,8 23,0 +1,1 +1,1
General viral induced proteins
Proteasome subunit beta type-6 precursor Ssa#STIR04422 21,4 21,4 +1,0 +1,1 23,3 22,4 +1,1 +2,3
Proteasome subunit beta type-6 precursor Ssa#STIR02309 21,3 21,4 +1,0 +1,0 23,2 22,4 +1,2 +2,5
14 kda transmembrane protein Ssa#STIR00068_4 21,5 21,4 +1,2 +1,8 23,1 21,6 +1,3 +3,1
Proteasome subunit beta type-6 precursor Ssa#STIR09223 21,4 21,4 +1,0 +1,1 23,2 22,4 +1,1 +2,4
Anti-viral protein
Ferritin, lower subunit putative mRNA Ssa#STIR07882 +1,3 +1,1 +1,2 +1,5 25,0 22,9 21,1 +4,1
Retroviral DNA integration
Barrier-to-autointegration factor Ssa#CL95Contig1 21,4 22,6 +1,6 +3,1 212,4 211,0 +1,9 +3,5
Prob. ATP-dependent RNA helicase DHX58 DW582483 21,2 22,9 +1,9 +1,6 24,3 25,3 +4,1 +5,5
Prob. ATP-dependent RNA helicase DHX58 DW567942 21,5 22,2 +1,1 +1,6 26,3 26,1 +1,7 +2,5
Transcripts, with probe names or accession number (when possible), are arranged by functional categories and the data are presented as the expression ratio between
the functional diet group and the standard group (ST/FF1 and ST/FF2), for each time point.
doi:10.1371/journal.pone.0040266.t004
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There was extremely good agreement between the microarray
results and the RT-qPCR quantification with 93% of
comparisons (67 out of 72) showing identical regulation with
very similar fold differences (Table 11). This analysis indicates
that the gene expression data obtained using the oligoarray
were reliable and robust, which enabled interpretations to be
made with some confidence, at least with regards to immune
response-related genes.
Discussion
This study demonstrated that a clinical nutrition approach
through the use of functional feeds significantly reduced viral
load in the heart tissue and resulted in significantly lower heart
pathology over the course of the experiment. There was also a
corresponding lower expression of inflammatory and immune
markers in heart tissue of fish fed the functional feeds.
There are several studies evaluating the modulation of
inflammatory responses to bacterial or viral infections in fish fed
diets formulated with different lipid sources [37–40]. In general,
diets containing high inclusion of VO, particularly n-6 PUFA-rich
oils such as soybean [39] or sunflower [40], have lower n-3/n-6
PUFA and EPA/ARA ratios, which can lead to increased pro-
inflammatory responses in fish. This is a consequence of the
production of pro-inflammatory eicosanoids (e.g. LTB4, TXA2
and PGE2) derived from ARA released from cell membrane
phospholipids of, especially, immune-related cells [32]. In the
present study, a high quality feed with a commercial formulation
served as a standard reference diet (ST), with protein supplied by a
mixture of fishmeal and plant meals, and FO and rapeseed oil as
the main lipid sources. Functional feeds were designed with
reduced lipid content and relatively small changes in fatty acid
composition focussed on increasing supply of EPA in the form of
phospholipid. The hypothesis was that these changes in dietary
Table 5. Innate immune system-related genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2)
relative to the standard diet during the course of the infection with ASRV.
Accession or 8 weeks 10 weeks 12 weeks 16 weeks
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2
Innate Immune system
Platelet basic protein precursor EG823365 22,5 25,0 +1,1 21,3 217,3 27,0 21,2 +3,9
Platelet basic protein EG761718 21,9 23,0 21,5 21,2 214,7 27,0 +1,2 +4,0
c-c motif chemokine 19 precursor Ssa#STIR10724 21,7 21,5 21,1 +1,0 25,2 22,7 21,3 +6,2
Ubiquitin-like protein BG936428 21,2 22,0 +1,7 +1,8 211,1 25,3 +1,3 +4,1
Skin mucus antibact. l-amino acid oxidase Omy#CA377250 24,1 21,8 +1,1 +1,3 227,8 223,4 +2,1 +3,1
C-C motif chemokine 19 precursor DW571080 23,3 24,0 +1,1 +1,2 212,3 27,2 +1,2 +3,5
Skin mucus antibact. l-amino acid oxidase DY698830 22,1 22,0 +1,2 +1,4 215,1 29,1 +1,9 +2,7
Chemokine (c-c motif) ligand 19 Ssa#STIR04367 22,5 22,6 +1,3 +1,4 25,9 23,5 +1,5 +3,7
Chemokine (c-c motif) ligand 19 Ssa#STIR21382 22,1 21,9 +1,2 +1,3 26,2 23,4 +1,5 +3,6
Interferon regulatory factor 7 BX307182 21,5 21,7 +1,1 +1,2 25,0 23,7 +1,7 +3,3
Neutrophil cytosolic factor 2 Ssa#KSS461 21,1 22,8 +1,4 +2,0 22,6 22,0 21,2 +1,9
Grn protein Ssa#STIR07488 21,3 21,4 +1,2 +1,4 23,7 22,4 +1,2 +2,6
Engulfment adaptor ptb domain contain. 1 Ssa#STIR11362 +1,7 21,9 24,9 25,2 22,5 +1,3 +1,3 +4,4
Granulocyte colony-stimulating factor R prec Ssa#STIR20316 +1,2 +1,3 21,0 21,6 21,4 21,2 21,2 +4,7
Interferon regulatory factor 7 DY725939 21,5 22,0 +1,0 +1,1 25,2 24,0 +1,5 +2,2
Interferon regulatory factor 7 Ssa#STIR00062_4 21,8 22,3 +1,2 +1,4 25,0 24,0 +1,4 +2,2
Interferon regulatory factor 7 Ssa#TC107831 21,6 21,6 +1,1 +1,3 25,9 24,1 +1,4 +2,3
Interferon regulatory factor 7 Ssa#STIR00062_3 21,6 21,9 +1,1 +1,3 25,1 23,8 +1,4 +2,1
Bloodthirsty Ssa#DY699301 22,0 +1,1 21,2 +1,0 213,4 25,7 +1,5 +2,4
Interferon regulatory factor 7 Ssa#STIR00062_2 21,4 21,7 +1,1 +1,4 24,6 23,8 +1,4 +2,2
Immune-related, lectin-like receptor 4 CB511660 +1,1 +1,0 +1,3 +1,2 22,8 21,7 21,1 +3,0
Cysteine dioxygenase Ssa#STIR21327 +1,1 21,0 21,2 +1,0 23,1 22,3 21,3 +2,7
Sub-fam. B ATP-binding cassette transport 2 DW563628 21,2 21,2 21,1 21,2 24,2 22,9 +1,5 +1,9
Tripartite motif-containing protein 35 EG878686 21,4 21,3 21,1 +1,2 23,6 22,8 +1,4 +2,0
Rho-related GTP-binding protein RhoG Ssa#KSS4662 21,2 21,4 +1,1 +1,2 22,9 21,9 21,1 +1,9
RAB26, member RAS oncogene family Omy#BX082318 21,9 22,3 +1,3 +1,5 22,7 21,7 21,0 +2,0
fMet-Leu-Phe receptor Ssa#STIR17576 21,2 21,2 21,1 +1,1 22,6 21,7 +1,1 +2,8
Bactericidal permeability-increasing protein DW540097 21,2 21,6 +1,2 +1,6 23,2 22,2 21,0 +2,0
TNFa-induced protein 8-like protein 2 Ssa#STIR00030_4 +1,1 21,1 +1,1 +1,2 22,3 21,5 21,1 +2,0
Transcripts, with probe names or accession number (when possible), are arranged by functional categories and the data are presented as the expression ratio between
the functional diet group and the standard group (ST/FF1 and ST/FF2), for each time point.
doi:10.1371/journal.pone.0040266.t005
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formulation would increase the potential bioavailability of EPA by
increasing its relative proportion in tissue phospholipids, and thus
mitigate the inflammatory response to ASRV infection in fish fed
the functional feeds. One analytical tool was the oligoarray, and
the present trial clearly demonstrated the utility of the Atlantic
salmon 44 k microarray for transcriptomic analysis and the
evaluation of a large number of genes involved in many metabolic
pathways. The oligoarray results provided an overview of when
and how the immune response developed after an infection with
ASRV and, especially, how changes in diet (feed formulation)
influenced the magnitude and progression of these processes.
In addition, a further hypothesis was that the mechanism
whereby increased EPA availability in fish fed the functional feeds
could affect immune response would involve eicosanoid pathways.
Although heart is the main organ affected in fish suffering HSMI,
head kidney is an important immune-related tissue in fish
producing macrophages, monocytes, B cells and other immune-
related cells [19]. Thus, as macrophages are a major source of
eicosanoids, the fatty acid profiles of both organs were determined
to define the precise effects of the different feeds on key tissue
compositions. Although the fatty acid profile of the heart tissue was
more conserved during the course of the infection, the higher
levels of EPA in the functional feeds was reflected in this organ,
with the proportion of EPA and the EPA/ARA ratio being
significantly higher in both groups of fish fed the FF diets.
However, head kidney fatty acid profile showed more extensive
differences in fatty acid composition, not only between fish fed the
ST diet and fish fed the FF feeds, but also during the time course
Table 6. IFN I related-genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2) relative to the standard
diet during the course of the infection with ASRV.
Accession or 8 weeks 10 weeks 12 weeks 16 weeks
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2
JAK-STAT signal transduction pathway
Suppressor of cytokine signaling 1 Ssa#STIR25114 22,1 22,1 21,1 +1,4 27,0 25,1 +1,6 +2,5
IFN-inducible protein Gig2-like Ssa#EG876062 21,3 21,6 21,1 +1,4 25,4 23,3 +1,9 +2,3
Suppressor of cytokine signaling 1 DW563373 21,6 21,4 21,1 +1,2 26,8 23,8 +1,5 +2,6
N-myc (and stat) interactor Ssa#STIR09454 21,3 21,5 +1,1 +1,1 23,1 22,3 +1,2 +2,1
IFN-inducible protein Gig2-like Ssa#EG871163 21,3 21,4 21,1 +1,1 23,2 22,5 +1,4 +2,1
JAK3 tyrosine kinase Ssa#DY728848 +1,3 +1,1 +1,1 21,2 22,7 21,7 21,1 +2,0
STAT 1 Ssa#STIR06397 21,3 21,4 +1,0 +1,0 23,3 22,5 +1,4 +1,6
STAT 1a EU016199 21,2 21,3 +1,1 +1,1 23,0 22,4 +1,5 +2,0
JAK1 Ssa#DW006200 21,2 21,3 +1,5 +1,3 23,0 22,4 +1,2 +2,0
Interferon inducible
IFN inducible mx protein U66475 21,8 22,3 +1,0 +1,2 213,9 28,9 +2,1 +3,7
IFN inducible mx protein Ssa#STIR00154_2 21,8 22,2 +1,0 +1,2 214,0 28,3 +2,1 +3,7
Vig-2 protein Ssa#STIR08402 21,4 22,5 +1,1 +1,7 215,2 29,2 +1,7 +2,6
Mx2 protein mRNA complete cds Con_CANDS_07 21,7 21,9 +1,0 +1,1 211,8 27,6 +2,4 +4,0
14 kda transmembrane protein Ssa#STIR17386 21,7 23,1 +4,9 +4,3 21,2 +1,5 21,2 +4,1
Myxovirus resistance 2 U66476 21,5 21,7 +1,1 +1,2 211,3 27,4 +2,3 +3,7
IFN inducible mx protein Ssa#STIR00154_3 21,6 21,8 +1,0 +1,2 28,3 25,9 +1,7 +2,9
Mx1 protein mRNA complete cds Con_CANDS_06 21,5 21,8 +1,0 +1,1 28,6 25,9 +1,7 +2,8
IFN inducible mx protein Ssa#STIR00154_4 21,8 21,9 +1,0 +1,2 28,3 26,0 +1,8 +2,7
IFN-induced GTP-binding protein Mx Ssa#STIR21272 21,9 22,5 +1,1 +1,3 28,6 26,9 +1,6 +2,1
vig-2 protein Ssa#STIR10385 21,3 21,7 +1,1 21,0 27,1 24,5 +1,4 +2,4
Mx3 protein U66477 21,5 21,7 +1,0 +1,1 27,6 25,0 +1,8 +2,5
IFN inducible mx protein Ssa#STIR00067_3 21,5 21,6 +1,0 +1,1 27,6 25,0 +1,8 +2,3
Cholesterol 25-hydroxylase-like protein A DW536322 22,1 +1,0 +2,1 +2,4 26,5 21,7 +1,3 +2,4
IFN-induced protein with tetratricopeptide Ssa#STIR00073_2 22,3 21,8 21,0 +1,1 24,5 23,9 +1,4 +1,6
IFN-induced guanylate-binding protein 1 Ssa#STIR18623 21,0 21,1 +1,2 +1,2 24,6 23,0 +1,0 +2,9
IFN-induced guanylate-binding protein 1 DY713986 21,0 21,4 +1,3 +1,3 24,2 23,6 +1,3 +2,4
14 kda transmembrane protein Ssa#STIR22465 21,4 21,4 +1,2 +1,6 22,9 21,6 +1,2 +2,7
IFNc induc. lysosomal thiol reductase precur Ssa#STIR04691 21,1 21,3 21,1 +1,0 22,1 21,5 21,3 +2,1
IFN-induced transmembrane protein 3 CA387902 21,4 21,5 +1,2 +1,5 22,4 21,3 +1,3 +2,7
Guanylate binding protein 3 Ssa#STIR19322 21,2 21,2 +1,3 +1,7 23,8 23,3 +1,3 +2,3
Transcripts, with probe names or accession number (when possible), are arranged by functional categories and the data are presented as the expression ratio between
the functional diet group and the standard group (ST/FF1 and ST/FF2), for each time point.
doi:10.1371/journal.pone.0040266.t006
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of the infection, including decreased ARA. These data confirm
that salmon consuming the functional feeds did indeed display
higher absolute and relative levels of EPA, which could increase its
potential bioavailability for eicosanoid synthesis. The data also
suggested that head kidney showed signs of a mobilization of key
fatty acids, especially ARA, during the course of the infection.
The results from the histological examinations showed that fish
fed the ST diet had relatively high scores 12-weeks after ASRV
inoculation, as reported in previous studies describing the
aetiology of HSMI [1,5]. Histopathology scores from the ST-fed
group showed that half of the fish sampled had major inflamma-
tion of the heart tissue at 12-weeks, and that the inflammatory
changes were even greater at the end of the experiment. In
contrast, fish fed the functional feeds were relatively unaffected by
the disease at 12-weeks. Furthermore, at later time points, when
inflammation was observed, it was less severe than in fish fed the
ST diet. These data are consistent with our overall hypothesis that
increasing dietary EPA and reducing dietary energy content would
be beneficial in reducing the severity of the disease through the
salmon experiencing a milder inflammatory response. However,
the results also showed that the fish fed the FF1 diet showed the
lowest inflammatory scores and, therefore, supplementation of
EPA in the form of krill oil, as in the FF2 diet, was not more
effective than simply supplying it as FO. Although the EPA/ARA
ratio was higher in the FF1 diet than in the FF2 diet, the similarity
in lipid content and fatty acid profiles of the two functional feeds,
and the tissues of salmon fed the diets, suggests that another
dietary factor could underlie the differences in immune response
[41]. Therefore, the precise reason for the difference between the
two functional feeds is not clear at present.
Transcriptomic analyses have been used recently to assess
changes in the expression of immune-related genes in viral
infections [25,27,42], but these studies have focussed on the early
stages of the infection as, in some cases, the high virulence of the
virus caused mortalities early in the infection. In the present study,
the slow replication of ASRV and the low mortality previously
recorded during HSMI outbreaks [1,5] enabled us to evaluate the
immune response over a much longer term. In most microarray
studies, clustering methods are commonly used where a wide
range of genes require organization [27,43]. The graphical display
of the gene categories, and their pattern of expression during the
course of the infection, enabled clear discrimination of when, and
Table 7. Antiviral host responses related-genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2)
relative to the standard diet during the course of the infection with ASRV.
Accession or 8 weeks 10 weeks 12 weeks 16 weeks
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2
Acute phase
Serum amyloid A-5 protein Ssa#KSS3451 21,7 22,2 +1,3 21,3 25,3 23,0 +2,1 +4,3
Serum amyloid a-5 protein Ssa#CK882427 21,7 22,3 +1,4 21,3 25,1 22,9 +2,2 +4,0
CCAAT/enhancer-binding protein beta Ssa#CL285Ctg1 21,2 21,2 +1,5 +2,0 22,1 +1,0 +1,4 +2,4
LBP (LPS binding protein)/BPI like-2 Ssa#KSS5230 21,2 21,1 +1,1 +1,3 23,3 22,1 +1,0 +2,8
Cathelicidin EG840650 +1,2 +1,3 21,4 +1,1 23,7 22,0 +1,9 +5,4
Natural killer cells
Granzyme A precursor EG853597 +1,1 +1,7 +1,2 +1,6 226,6 29,1 23,2 +5,5
Interleukin 18 form a, IL-18A AJ556990 21,0 +1,1 +1,2 +1,1 21,2 +1,1 21,3 +2,1
Immune-lectin-like receptor 3 Ssa#STIR08687 +1,0 21,0 +1,2 +1,0 21,8 21,2 21,0 +1,9
Interleukin 12b Ssa#STIR00077_3 21,2 21,6 +1,3 +1,2 21,4 21,2 +1,3 +1,6
Perforin-1 precursor CB515603 21,2 21,1 +1,1 21,2 21,4 21,3 +1,3 +1,9
Apoptosis
Mgc81823 transcript variant 2 Omy#TC159807 21,0 21,2 +1,1 +1,1 27,8 24,1 21,2 +4,1
Cathepsin l precursor Omy#CX262263 21,3 21,2 +1,1 +1,0 28,2 24,1 21,1 +4,0
Cathepsin l Ssa#STIR23260 +1,0 21,0 +1,2 +1,1 27,9 24,5 21,2 +3,8
E3 ubiquitin-protein ligase LINCR DY697357 +2,2 21,0 22,0 +1,2 210,9 22,1 21,4 +4,5
Caspase-14 precursor EG868944 21,3 21,5 +1,0 +1,4 26,2 24,5 21,2 +2,4
Caspase 14 Ssa#STIR02208 21,4 +2,1 +1,4 23,6 22,0 +1,2 24,5 +1,8
E3 ubiquitin-protein ligase RNF144A-A EG829820 21,7 21,5 +1,1 +1,4 26,0 24,2 +1,0 +2,0
E3 ubiquitin-protein ligase RNF144A-A EG841469 21,3 21,7 +1,2 +1,2 25,9 23,3 +1,0 +2,5
AN1, ubiquitin-like, homolog Omy#CU065924 21,2 23,4 +1,1 21,5 21,9 +1,5 21,4 21,3
Ubiquitin carboxyl-terminal hydrolase
iso L5
Ssa#S35587724_S 21,9 22,1 +1,0 +1,4 21,5 21,1 21,8 +2,7
Ubiquitin specific protease 18 EG868088 21,3 22,1 21,1 +1,1 24,2 23,5 +1,5 +1,9
Tripartite motif-containing protein 39 DW545632 21,5 21,8 +1,3 +1,4 24,1 24,0 +1,1 +2,1
Tyrosine-protein kinase Lyn Omy#CX255862 21,1 21,5 +1,2 +1,2 22,4 21,8 21,1 +2,0
Transcripts, with probe names or accession number (when possible), are arranged by functional categories and the data are presented as the expression ratio between
the functional diet group and the standard group (ST/FF1 and ST/FF2), for each time point.
doi:10.1371/journal.pone.0040266.t007
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in which dietary treatment, the major responses occurred. The
cluster analysis showed that, at early stages of the infection, 8- to
10-weeks post-challenge, there were only relatively minor differ-
ences in gene expression between fish fed the different dietary
treatments, whereas there was strong up-regulation of immune-
related genes 12-weeks post-challenge in fish fed the ST diet
compared to fish fed the FF1 and FF2 diets. Similar up-regulation
of the same gene set was observed 16-weeks post-infection in fish
fed the FF2 diet whereas fish fed the FF1 diet did not show a
similar up-regulation of this gene set during the time-course of the
experiment. Although the modification of expression of some
immune related genes by functional feeds has been reported
previously [11], clear differential effects of feeds on gene
expression patterns, as displayed in the cluster analysis in the
present study, are largely unprecedented and not previously
reported in fish. The markedly different modulation of gene
expression confirms that changes in dietary composition, including
lipid content and source, and relatively small changes in fatty acid
profiles, may influence the severity of the immune response.
The transcriptome analysis revealed a clear correlation between
the severity of histopathological lesions and activation of the innate
immune response in heart tissue. A similar correlation was
described in previous studies on viral infections in salmon,
specifically ISAV [25] and PMCV [44], the latter being the
Table 8. IFN II-related genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2) relative to the standard
diet during the course of the infection with ASRV.
Accession or 8 weeks 10 weeks 12 weeks 16 weeks
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2
Induction proliferation and
maduration of T-cells
T-cell receptor a chain V region 2B4
precur.
EG773958 21,3 25,2 23,9 22,0 22,7 21,4 22,4 +3,1
T-cell receptor b chain AJ517930 21,1 22,0 +2,1 +1,5 24,8 21,8 21,2 +3,9
Differentially expressed in FDCP 6
homolog
Ssa#S48397573 21,7 21,8 21,1 +1,1 26,2 23,2 +1,9 +2,2
Immediate early response gene 2
protein
DW562838 21,5 21,6 +3,6 +5,8 +1,1 +2,3 +1,2 21,0
CD9 antigen CB515563 21,4 21,2 21,1 +1,2 24,2 23,1 +1,4 +2,5
T-cell receptor a chain V region 2B4
precur.
EG890703 22,2 21,6 21,7 21,4 21,7 21,4 +1,5 +3,2
Core-binding factor beta subunit Ssa#TC107774 21,5 22,2 21,2 +1,1 22,9 21,6 +1,0 +3,1
CD97 antigen EG935955 21,3 21,3 +1,3 +1,2 23,1 22,3 21,0 +2,4
Rho-related GTP-binding protein RhoG Ssa#KSS4662 21,2 21,4 +1,1 +1,2 22,9 21,9 21,1 +1,9
Ras homolog genemember g Ssa#STIR25495 21,3 21,5 +1,1 +1,2 22,4 21,7 21,0 +1,9
Ras homolog genemember g Ssa#STIR05697 +1,1 21,2 21,6 +1,2 22,9 21,5 +1,3 +2,2
Hemopoietic cell kinase partial cds AF321110 21,0 21,1 +1,2 +1,2 22,6 21,7 +1,1 +2,2
Tyrosine-protein kinase SRK2 Ssa#STIR23204 21,8 21,8 +1,2 +1,4 23,9 24,0 +1,3 +2,0
Galectin-9 putative mRNA Ssa#STIR13309 21,2 21,3 21,1 +1,1 24,3 22,5 +1,1 +1,9
Galectin like protein Ssa#STIR12085 21,2 21,3 21,1 +1,1 24,3 22,6 +1,1 +1,8
CD80-like protein EG933501 +1,2 +1,1 +1,1 +1,2 21,7 21,3 +1,0 +2,3
C-C motif chemokine 28 precursor Ssa#STIR03768 21,5 22,0 21,7 +9,3 +2,1 23,7 +1,5 +2,7
Cellular immunity
Interferon gamma AJ841811 21,8 22,1 +1,0 21,2 210,1 24,4 21,1 +6,4
Interferon gamma Ssa#STIR00056_4 21,7 21,6 21,4 21,2 211,1 24,7 21,0 +4,5
Interferon gamma 2 Omy#gi238231582 21,3 22,4 +1,2 +1,4 25,8 24,1 21,0 +4,6
Interferon gamma Ssa#STIR00056_3 +1,0 21,1 +1,0 22,0 29,4 25,7 21,3 +3,0
Tripartite motif-containing protein 47 Ssa#DY714453 21,1 21,1 21,4 21,2 25,4 21,9 +2,2 +5,6
TRIM 16 protein EG875618 21,6 21,7 21,0 +1,3 23,7 23,3 +1,6 +2,4
Beta-2 microglobulin AF180490 21,3 21,3 +1,0 +1,0 22,6 22,1 +1,1 +1,8
Tapasin-related protein DW567893 21,2 21,1 21,1 21,1 22,4 21,9 +1,1 +1,4
CD83 antigen precursor Ssa#KSS3110 21,1 21,0 +1,6 +1,6 21,9 21,6 21,2 +1,4
CD80-like protein EG933501 +1,2 +1,1 +1,1 +1,2 21,7 21,3 +1,0 +2,3
Tapasin DQ451008 21,3 21,5 +1,1 +1,1 22,6 22,1 21,0 +1,4
TAP2 protein DW580644 21,4 21,6 +2,2 +2,7 21,7 22,3 21,4 21,1
Transcripts, with probe names or accession number (when possible), are arranged by functional categories and the data are presented as the expression ratio between
the functional diet group and the standard group (ST/FF1 and ST/FF2), for each time point.
doi:10.1371/journal.pone.0040266.t008
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causal agent of cardiomyopathy syndrome (CMS). Furthermore,
the transcriptome analysis uncovered important players in the
immune response, aiding its characterization. Up-regulation of
genes related to antiviral host responses was observed when the
heart lesions were higher, and this also correlated with the higher
viral load (12-weeks post-challenge for fish fed ST diet and 16-
weeks post-challenge for fish fed the other diets, particularly FF2).
Therefore, genes like barrier-to-autointegration factor, chemokine
19, platelet basic protein, gig-2, galectin-9 among others, and
those genes related to apoptosis, were strongly up-regulated.
Although up-regulation of similar suites of genes was reported in
earlier studies on common salmon viral diseases [28,25,44], fold-
changes as high as those obtained in the present study have not
been reported previously. This could be related to improvements
in oligomicroarray technology but, most likely, also to the longer
duration of the present experimental design.
When viral load are high, interferon regulatory factors (IRF) are
induced to activate the transcription of type I interferon (IFN)
[45]. In the present study, the expression of IRF7 was up-
regulated. Although type I IFNs were not present in the up-
regulated list, the activation of genes for proteins of the JAK-
STAT signalling pathway, which may result in increased
expression of Mx proteins, and of Vig-2 and cholesterol 25-
hydroxylase, the latter being an enzyme of steroid biosynthesis
activated with type I IFNs in mammalian macrophages [46],
indicate molecular mechanisms inducing immune pathways in
ASRV infection. Consequences of activation of this pathway could
include stimulation of natural killer cells (NK), confirmed in our
list by strong up-regulation of granzyme A, and receptors found in
NK cells such as CD229, and T cell receptor a. Activation of IFN
I could lead to increased expression of major histocompatibility
complex (MHC) class I to promote antigen presentation activa-
tion. However, although genes related to MHC I such as beta-2
microglobulin and TAP proteins were up-regulated (see Table 6),
it appears that activation of this pathway may not be as important
in ASRV infection as it is in other viral infections such as ISAV
[47]. The previous ISAV study was performed at early stages of
the infection in comparison to the much longer time scale of the
present study, and so this may indicate that the importance or role
of different pathways varies during the progression of the infection,
Table 9. Adaptive immune system related-genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2)
relative to the standard diet during the course of the infection with ASRV.
Accession or 8 weeks 10 weeks 12 weeks 16 weeks
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2
Innate to adaptive
MHC class II antigen beta chain Ssa#STIR00007_3 21,2 24,5 216,5 24,2 23,1 +1,2 +41,0 +15,0
MHC class II antigen beta chain Ssa#STIR00007_4 +1,3 22,4 236,5 27,4 22,1 21,2 +70,6 +27,4
IFNc-inducible lysosomal thiolreductase prec. Ssa#STIR09719 21,1 21,3 21,0 +1,0 22,1 21,5 21,3 +2,1
IFNc-inducible lysosomal thiolreductase prec. Ssa#STIR04691 21,1 21,3 21,1 +1,0 22,1 21,5 21,3 +2,1
Chemokine (c-x-c motif) ligand 13 Ssa#STIR03818 22,7 21,6 21,1 +1,0 24,8 22,3 +3,8 +13,1
CC chemokine Ssa#STIR23541 21,5 21,4 +1,5 21,4 25,0 23,4 +1,6 +5,2
CD226 antigen DW553192 22,2 22,2 +1,6 +1,2 23,5 21,4 +1,9 +6,5
TNF superfamily member 14 Ssa#S31975856_S 25,9 23,2 +1,4 21,0 25,2 21,5 21,2 +4,4
Chemokine cxcl-c1c Ssa#STIR11364 21,6 21,6 +1,1 +1,2 25,1 23,0 +1,7 +3,5
High affinity IgG fc receptor i precursor Ssa#STIR11789 22,6 21,1 21,9 +1,4 22,4 23,0 +1,3 +3,2
High affinity IgE receptor subunit c precur. Ssa#STIR03935 21,1 21,2 +1,0 +1,2 22,8 22,0 21,0 +2,4
High affinity IgG fc receptor i precursor Ssa#STIR24788 21,3 21,5 +1,1 +1,2 22,8 21,8 +1,0 +2,2
High affinity IgE receptor subunit c precur. Ssa#STIR08428 21,1 21,3 +1,0 +1,2 22,8 22,0 21,0 +2,4
High affinity IgE receptor subunit c precur. Ssa#STIR09946 21,1 21,3 +1,0 +1,2 22,7 22,0 +1,0 +2,4
High affinity IgE receptor subunit c precur. Ssa#STIR05473 21,1 21,2 +1,1 +1,2 22,7 21,9 21,0 +2,3
Chemokine (c-x-c motif) receptor 3 Ssa#STIR10673 21,1 21,2 +1,5 +1,2 22,7 22,0 +1,1 +2,3
Chemokine (c-x-c motif) ligand 10 Ssa#STIR02663 21,1 21,1 +1,1 +1,1 22,6 22,3 +1,2 +2,2
C-X-C chemokine receptor type 3A, variant 1 AJ888878 +1,1 +1,0 +1,1 +1,2 22,3 21,7 21,0 +2,4
Humoral immunity
Interleukin 20alpha Ssa#STIR13743 +1,0 21,7 +1,3 +2,2 210,6 210,6 22,2 +1,9
PREDICTED: similar to CD22 molecule CU073328 +2,2 21,2 +1,3 21,8 25,2 21,4 24,0 +1,3
Interleukin 20alpha Ssa#STIR18005 +1,0 21,2 +1,2 +1,1 23,0 22,0 21,0 +2,2
Interleukin 10beta Ssa#STIR00087_3 21,7 21,7 +1,1 +1,3 24,1 23,2 +1,5 +1,9
Leukocyte surface antigen CD53 EG836748 21,0 21,1 +1,2 +1,3 22,3 21,6 21,1 +2,2
TNFR superfamily member 5 Ssa#CL366Ctg1 21,1 21,1 +1,2 +1,4 22,1 21,6 +1,2 +2,2
B-cell linker protein Ssa#KSS4516 +1,2 +1,3 21,0 +1,2 21,9 21,2 +1,4 +2,5
Transcripts, with probe names or accession number (when possible), are arranged by functional categories and the data are presented as the expression ratio between
the functional diet group and the standard group (ST/FF1 and ST/FF2), for each time point.
doi:10.1371/journal.pone.0040266.t009
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as would be expected. The activation of NK cells, the prominent
up-regulation of genes associated with cytotoxic T cells (T-cell
receptor a and b chains, CD97 and CD9), and up-regulation of
interleukins 12 and 18 will likely result in increased IFN II (IFN-c),
which was also shown to be up-regulated. This up-regulation is in
agreement with the induction of the IFN II responses reported
previously in viral infections of salmon, specifically ISAV [47],
IPNV [48] and PMCV [44]. As was reported previously, the
activation of the cytotoxic T cells after infection with PMCV seems
to be a prominent feature of the immune system for clearance of
the viral infection [44]. As LC-PUFA have been shown to
modulate the production of IFN-c, [49], the differences in the
levels of EPA and in the EPA/ARA ratio between the diets may
contribute to the differential immune responses observed although,
as described above, the differences in LC-PUFA between the two
functional feeds were relatively small.
The present study also showed up-regulation of MHC class
II that may indicate an important humoral immune response
to ASRV. In contrast, up-regulation of this gene was not
observed in salmon in response ISAV at early stage infection
[47]. The 70-fold higher expression of MHC class II in fish fed
the FF1 diet at 16-weeks post-infection, when viral load was
high, compared with those fed the ST diet, could be indicative
of a more efficient response against ASRV at that time in fish
fed FF1.
In general, the expression of all genes characteristic of the
immune response was different between the dietary treatments,
not only in terms of the time-courses of ASRV infection and
response, but also when comparing gene expression in fish
presenting high viral load, with consistently lower expression in
fish fed the FF1 diet. The less extreme effects on immune gene
expression, especially those of the innate immune response, may
be indicative of a milder/controlled response in fish fed the FF1
diet, and the reason why fish on this treatment presented fewer
and less severe heart lesions. This is consistent with previous data
on salmon challenged with ISAV that showed fish with the highest
expression of genes involved in the innate immune response were
those with low resistance to the disease [25]. Therefore, it appears
that in viral diseases like HSMI, with lower mortality but high
morbidity, the control of over-expression of genes involved in
antiviral host responses could be key to better performance of the
fish.
Table 10. Lipid-related inflammatory pathway genes differentially expressed in heart of fish fed the functional feeds (FF1 and FF2)
relative to the standard diet during the course of the infection with ASRV.
Accession or 8 weeks 10 weeks 12 weeks 16 weeks
BlastxHit probe number FF1 FF2 FF1 FF2 FF1 FF2 FF1 FF2
Inflamatory pathways
Leukotriene B4 receptor 1
(LTB4-R 1)
DW558098 21,0 +1,1 +1,2 +1,1 22,6 21,5 +1,4 +3,4
Arachidonate 5-
lipoxygenase
Ssa#DW575444 +1,2 +1,2 +1,0 +1,1 21,6 21,2 21,1 +1,9
Transcripts, with probe names or accession number (when possible), are arranged by functional categories and the data are presented as the expression ratio between
the functional diet group and the standard group (ST/FF1 and ST/FF2), for each time point.
doi:10.1371/journal.pone.0040266.t010
Table 11. RT-qPCR validation of microarray results.
12 weeks 16 weeks
FF1 FF2 FF1 FF2
Microarray qPCR Microarray qPCR Microarray qPCR Microarray qPCR
IL10 23.89 23.73 23.31 22.87 +1.50 +1.32 +1.85 +1.13
Casp14 26.19 24.82 24.50 22.47 21.15 21.33 +2.39 +1.57
TCRa 22.70 22.34 21.39 21.32 22.37 21.58 +3.07 +1.26
IRF1 22.45 22.56 21.90 21.57 21.10 21.10 +1.82 +1.40
MX1 213.88 213.57 28.87 28.44 +2.08 +2.06 +3.66 +2.48
INFII 29.36 28.48 25.74 24.58 21.28 21.91 +3.01 +1.25
GIG2 25.41 25.59 23.34 24.41 +1.95 +2.06 +2.34 +1.69
SAA 25.07 23.95 22.90 22.43 +2.20 +1.74 +4.01 +2.00
FLAP 21.50 21.26 21.23 +1.34 +1.12 +1.01 +2.04 +1.42
BAF 212.38 211.99 211.02 211.78 +1.88 +1.82 +3.47 +2.03
B2M 22.59 21.83 22.11 21.68 +1.11 21.54 +1.79 21.49
IgER 22.23 22.18 21.68 21.35 21.04 21.22 +2.03 +1.22
Values represent the expression ratios for the selected genes between the functional diet group and the standard group at 12- and 16-weeks post-infection with ASRV
obtained by microarray analysis or RTqPCR.
doi:10.1371/journal.pone.0040266.t011
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Leukotriene LTB4 plays important roles in the immune
response, enhancing NK cell activity, stimulating lymphocyte
production of IFN-c, and modulating immune cell function
promoting the proliferation of T cells and stimulating the release
of cytokines from those cells [21,50]. As LTB4 is synthesized from
ARA derived from cell membrane phospholipids, it represents a
link between tissue LC-PUFA profiles and the expression of the
immune related genes mentioned above. Two genes in the up-
regulated list related to LTB4 metabolism, arachidonate 5-
lipoxygenase (LTB4 biosynthesis) and leukotriene B4 receptor,
were up-regulated two-fold when the viral load was high in fish fed
the ST and FF2 diets compared with fish fed the FF1 diet. This is
one example of how, early in the cascade of events of the immune
response, differences can be found between fish fed the FF1 diet
and fish fed the other diets. Differential expression of both these
genes was also reported after infection with ISAV [25], thus the
eicosanoid pathways appear to be important in salmon viral
diseases, determining the magnitude of the inflammatory response.
The present study has clearly demonstrated that application of
clinical nutrition and the use of functional feeds can have a major
influence on the development and severity of the response to
ASRV infection in salmon. Furthermore, the differences in gene
expression between fish fed the different diets have provided
further insight into the molecular mechanisms and progression of
the immune responses to ASRV infection in salmon. However, the
precise mechanisms underpinning both the delayed replication of
the virus in fish fed the functional feeds and the differential effects
of these two formulations require further investigation.
Conclusion
The present study is the first to describe the effects of functional
feeds on the expression of genes related to the immune response
after infection with ASRV. The long duration of the experiment
allowed us to evaluate the host-pathogen interaction, increasing
knowledge of HSMI, an important emerging disease in Atlantic
salmon aquaculture. Clear differences on viral load and the
immune response were found in fish fed the different dietary
treatments, highlighting the immune modulatory role of dietary
lipid content and composition in viral infections. Reduction in
dietary lipid along with increased EPA can lead to a milder
inflammatory response and consequently less severity of the heart
lesions caused by ASRV infection indicating that dietary
immunomodulation could reduce the morbidity of the disease
improving the performance of fish suffering HSMI.
Materials and Methods
Fish and experimental feeds
Three fishmeal-based diets were formulated and manufactured
by EWOS Innovation (Dirdal, Norway) (Table 12). The reference
diet (ST) was essentially a standard, commercial formulation with
31% lipid with the added oil being a blend of FO and rapeseed oil.
The two functional feeds (FF) both contained a lower level of lipid
that was balanced by increased protein, provided by fishmeal and
krill meal. Both also contained increased proportions of EPA, but
with different levels of n-6 PUFA and DHA, resulting in the n-3/
n-6 PUFA ratio in the feeds varying from 1.5 to 3.6, through the
inclusion of krill oil in one of the feeds replacing rapeseed oil
(Table 3). The precise formulations were based on small-scale
commercial screening trials (unpublished). Therefore, as one
major factor being investigated was dietary lipid level, the diets
were not isolipidic or isoproteic. The diets were termed ST
(standard reference diet), FF1 and FF2.
A total of 450 Atlantic salmon (Salmo salar L.), unvaccinated
AquaGen strain, were distributed into three tanks at the EWOS
facility, Lønningdal, Norway and fed one of the three feeds for a
period of 8 weeks. After this pre-challenge feeding phase, 390 (130
fish per treatment) fish (non-vaccinated) with an initial average
weight 220 g (63.2 g, standard error), were transferred to the
challenge facility at the Industrial and Aquatic Laboratory (ILAB),
Bergen, Norway. Fish were distributed into two independent
experimental rooms supplied with filtered sea water (of approx-
imately 30%) each containing 9 tanks (3 tanks per dietary
treatment in each system). Water delivery was flow-through, with a
supply to maintain oxygen concentration in outlet water .8 mg/
L. Water temperature was maintained at 1061uC, water flow rate
was 0.8 L/kg fish/min, and a 12:12 h light/dark regime was
followed. The fish were acclimated for 2 weeks prior to challenge
and were fed with the same diets during the acclimation period
and throughout the period of the challenge (16 weeks) that they
were fed prior to transfer. No previous diseases were described.
Ten fish from each feeding group (n= 30 in total) were sampled
prior to challenge (0 time-point controls) for histological exami-
nation to confirm they were disease-free.
ASRV Challenge
As this was a nutritional trial designed to test the effects of
different feeds, all 360 remaining fish were challenged with
pathogen. The fish were sedated using Aqui-S at final concentra-
tion of 5 mg/L of isoeugenol, followed by anaesthesia in Benzoak
using a final concentration of 30 ml/L of water. Fish were
challenged by intramuscular injection (0.1 ml on each side close to
the lateral line) of ASRV collected from cell culture supernatant of
piscine reovirus (see below). There were no mortalities during the
trial, which was consistent with previous experimental studies of
HSMI [1,5].
Virus isolation and preparation of inoculum
Heart tissue, collected from a clinical outbreak of HSMI, was
homogenized and centrifuged 35006g for 20 min 4uC to remove
cellular debris and then filtered (0.45 mm). The homogenate was
inoculated onto GF-1 cells derived from fin tissue of orange-
spotted grouper, Epinephelus coioides. This was done in collaboration
with PHARMAQ AS, Oslo, Norway who supplied the cell line.
The cells were grown at 15uC in Leibovitz L-15 medium
(Invitrogen AS, Oslo, Norway) supplemented with 1% L-
glutamine, 0.1% gentamicin sulphate (Sigma Aldrich Norway
AS, Oslo, Norway) and 10% fetal bovine serum (Invitrogen). At 2
weeks after inoculation the supernatant and cell lysate were
harvested and cleared by centrifugation at 35006g for 20 min at
4uC.
Sampling
Ten fish, chosen at random, from each dietary treatment group
(5 fish from each of the two independent systems) were sampled at
8-, 10-, 12-, and 16-weeks post-challenge for histology, lipid and
biomolecular analysis (data presented). However, in addition a
further 10 fish per treatment were sampled at 14 weeks post-
challenge for histology (data not shown) and all remaining fish
were culled at week 16 post-challenge for possible further
histological analysis. Fish were anaesthetized and killed by a blow
to the head, and heart and head kidney collected for analyses. Part
of each heart sample was transferred to 10% buffered formalin for
histological analyses and another part was immediately frozen in
liquid N2 and stored at 280uC prior to lipid and molecular
analyses. Head kidney was immediately frozen in liquid N2 and
stored at 280uC.
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Histological examinations
Inflammatory response in ASRV challenged fish was assessed
by histological changes in heart tissue (epicardium and myocar-
dium) as assessed by light microsopy. The scoring system marked
samples on a visual analog scale on the basis of the criteria given in
Table S3 [3]. A maximum score of 6 can be achieved for
combined epicardial and myocardial changes. All evaluations were
carried out blind. Further, details of the different feeds were not
revealed to the histological examiner (ØE), i.e. the histological
examination was carried out as a double-blind study.
Histological changes in epicardium and myocardium were
ranked according to a non-continuous score grade from 0 to 4 (0
indicates no pathology, normal tissue; 4 intense inflammation). A
description of each of the scores is included in Table S3.
All data preparation and simulation output analysis was
conducted with the R language [51]. The model was a mixed-
effects linear model estimated with the lmer function in the lme4
package. The treatment estimates were based on posterior
simulation (n = 2500) with 95% credible intervals as absolute
and proportional to the reference level (control diet).
Histopathological scores were analysed by using a multilevel
ordered categorical logistic regression because the data are
multinomial. The model was written in BUGS [52] language
and fitted with JAGS [53]. Vague non-informative uniform priors
[0,100] were given for the variance parameters and vague non-
informative normal priors N (0, 1.0E+4) for all other parameters.
25000 ‘‘burn-in’’ simulation runs were used to adapt the Markov
Chain Monte Carlo (MCMC) before subsequent 2500 runs that
were used for inference. Three chains were run in parallel, i.e.
there were a total of 7500 simulations for inference. These were
thinned so that only every 10th simulation was saved to reduce the
size of saved objects and to reduce the effects of autocorrelation. In
effect, the posterior density is based on 750 draws from the
posterior probability distribution. Convergence of the MCMC
simulation was judged by the so-called Gelman-Rubin conver-
gence diagnostic [54].
Lipid analyses
Lipid and fatty acid analyses were performed on heart and head
kidney tissue samples from five fish per treatment at 8- and 16-
weeks post-challenge. Total lipid from approximately 1 g of heart
and head kidney tissue was extracted by homogenization in
chloroform/methanol (2:1, by volume) according to Folch et al.
[55], and determined gravimetrically. Fatty acid methyl esters
(FAME) of total lipid were prepared by acid-catalyzed transmeth-
ylation [56], and FAME separated and quantified by gas
chromatography as described in detail previously [40]. Tissue
and diet lipid class compositions were determined by single-
dimension double-development high-performance thin-layer chro-
matography (HPTLC) and densitometry as described previously
[40]. Significance of differences due to diet and time were
determined by two-way ANOVA (p,0.05) using the SPSS 19.0
statistical package (SPSS Inc., Chicago IL, USA). Significance of
differences in heart fatty acid compositions due to diet at each time
point were determined by one-way ANOVA (p,0.05) (SPSS).
RNA extraction and purification
Heart tissue from six individuals per dietary treatment was
rapidly homogenized in TRI Reagent (Ambion, Applied Biosys-
tems, Warrington, U.K.) using an Ultra-Turrax homogenizer
(Fisher Scientific, Loughborough, U.K.). Total RNA was isolated
following manufacturer’s instructions, and RNA quality and
quantity assessed by gel electrophoresis and spectrophotometry
(NanoDrop ND-1000, Thermo Scientific, Wilmington, U.S.A.),
respectively. One hundred micrograms of total RNA from each
individual sample was further purified by mini spin-column
purification (RNeasy Mini Kit, Qiagen, Crawly, UK), and
quantified and quality assessed as above.
Microarray hybridizations and analysis
The transcriptomic experiment used an Atlantic salmon
custom-made oligoarray with 44 k features per array on a four-
array-per-slide format, with each feature printed singly (Agilent
Technologies UK Ltd., Wokingham, UK). The probes were co-
designed by researchers at the Institute of Aquaculture, University
of Stirling, U.K. and The Norwegian Institute of Food, Fisheries
and Aquaculture Research (Nofima, Tromsø, Norway), and array
design is available on request. A dual-labelled experimental design
was employed for the microarray hybridizations. Each experi-
mental sample was competitively hybridized against a common
pooled-reference sample, which comprised equal amounts of each
of the replicates used in the study. This design permits valid
statistical comparisons across all treatments to be made. The entire
experiment comprised 72 hybridizations; 4 time points (8, 10, 12
and 16 weeks)63 diets (ST, FF1 and FF2)66 biological replicates.
Indirect labelling methodology was employed in preparing the
microarray targets. Amplified antisense RNA (aRNA) was
produced from each RNA sample using the Amino Allyl
MessageAmpTM II aRNA Amplification Kit (Ambion, Applied
Biosystems, Warrington, UK), following the manufacturer’s
methodology, followed by Cy3 or Cy5 fluor incorporation through
a dye-coupling reaction. Briefly, 500 ng of total RNA per sample
were amplified and column-purified according to manufacturer’s
instructions including a 17 h transcription step. Resultant aRNA
was quantified and quality assessed as above. Subsequently, Cy
dye suspensions (Cy3 & Cy5) in sufficient quantity for all labelling
reactions were prepared by adding 36 mL high purity dimethyl
sulphoxide (Stratagene, Agilent Technologies UK Ltd.) to each
tube of Cy dye (PA23001 or PA25001, GE HealthCare, Chalfont
St. Giles, UK). To attach the Cy dyes, 3 mg each aRNA sample
was suspended in 10 mL nuclease-free H2O and heated to 70uC
Table 12. Formulation of the experimental diets.
Component %1 STD FF1 FF2
Fish meal and hydrolysates 42.1 53 53
Fish oil 13.7 7 5.2
Vegetable protein concentrates2 21 18 18
Vegetable oil 11.2 3 0
Carbohydrate-based binders3 11.2 12.1 12.1
Micro premixes4 0.8 1.9 1.7
Krill meal5 0 5 5
Krill oil5 0 0 5
Total 100 100 100
Proximate composition
Moisture 6.5 6.5 6.5
Fat 31 18 18
Protein 42.2 53.4 53.4
1)All ingredients sourced from EWOS stocks unless otherwise stated.
2)Includes soy protein concentrate, pea protein concentrate, wheat gluten and
sunflower meal.
3)Includes wheat grain.
4)Includes vitamins, minerals, crystalline amino acids, ammonium phosphate.
5)Aker Biomarine A.
doi:10.1371/journal.pone.0040266.t012
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for 2 min. When cooled to room temperature, 3 mL of coupling
buffer (0.5 M NaHCO3; pH 9.2) and 2 mL of Cy3 dye suspension
stock was added and then incubated for 1 h at 25uC in the dark.
To label the common pooled reference sample with Cy5, a scaled-
up batch reaction was similarly performed. Unincorporated dye
was removed by column purification (Illustra AutoSeq G-50 spin
columns; GE Healthcare). Dye incorporation and aRNA yield
were quantified by spectrophotometry (NanoDrop) and further
quality controlled by separating 0.4 mL of the sample on a thin
mini-agarose gel and visualising products on a fluorescence
scanner (Typhoon Trio, GE Healthcare).
Hybridization of a total of 6 slides (24 arrays) was performed in
a single day, with sample order semi-randomized, using SureHyb
hybridization chambers in a DNA Microarray Hybridization
Oven (Agilent Technologies). For each hybridization, 825 ng of
Cy3-labelled experimental biological replicate and Cy5-labelled
reference pool were combined and total volume made up to 38 ml
with nuclease-free water. A fragmentation master mix was
prepared containing, per reaction, 11 ml 106 blocking agent,
2.2 ml 256 fragmentation buffer and 6.8 ml nuclease-free water,
and 20 ml was dispensed into the Cy-dyes mix. After incubating in
the dark at 60uC for 30 min, 57 ml 26GE Hybridization buffer
(pre-heated to 37uC) was added, contents gently mixed, spun at
16,000 g for 1 min and kept on ice until loaded onto the
microarray slides as per the manufacturers protocol. Hybridization
was carried out in the oven rotator (Agilent Technologies) at 65uC
and 10 rpm for 17 h. Post-hybridization washes were carried out
in EasyDipTM Slide staining containers (Canemco Inc., Quebec,
Canada). After disassembling the array-gasket sandwiches sub-
mersed in wash buffer 1 at room temperature, the microarray
slides were transferred to an EasyDipTM container and incubated
in wash buffer 1 for 1 min at 31uC in an orbital incubator rotating
at 150 rpm, and then a further 1 min at 31uC at 150 rpm in wash
buffer 2. A final dip in wash buffer 2 at room temperature was
performed, after which the slides were dried by centrifugation
(5006g for 6 min) and kept in a desiccator in the dark until
scanned the same day. Unless otherwise stated, all reagents were
from Agilent Technologies.
Scanning was performed at 5 mm resolution using an Axon
GenePix 4200AL Scanner (MDS Analytical Technologies,
Wokingham, Berkshire, U.K.). Laser power was kept constant
(80%) and the ‘‘auto PMT’’ function within the acquisition
software (v.4) was enabled to adjust PMT for each channel such
that less than 0.1% of features were saturated and that the mean
intensity ratio of the Cy3 and Cy5 signals was close to one. Agilent
Feature Extraction Software (v 9.5) was used to identify features
and extract fluorescence intensity values from the resultant TIF
images. The remaining analysis was then performed in the
GeneSpring GX version 10.0.2 analysis platform (Agilent Tech-
nologies). All intensity values ,0.1 were set to 0.1 followed by a
block Lowess normalisation. After removing control features, a
series of four quality filtering steps was carried out sequentially
using a range of quality control metrics produced by the Agilent
Feature Extraction software to remove features that were
saturated, non-uniform, population out layers and spots non-
significantly different from background.
Hybridization data were analyzed by two-way ANOVA, which
examined the explanatory power of the variables ‘diet’ and ‘time’
and the interaction between the two, at a significance level of 0.05.
In the present study we focussed on immune-related genes whose
expression was differentially affected by diet at 16 weeks post-
challenge and thus only data from the significant interaction list
was analyzed. That list contained 2584 genes, including repeated
probes. Due to the large size of the list, hierarchical cluster analysis
and 565 Self-Organizing Maps cluster analysis (SOM) were used
to map the common temporal expression profiles of the genes from
the list using the GeneSpring GX version 10.0.2 analysis platform
(Agilent Technologies).
RT-qPCR
Expression of 12 selected genes showing a significant diet6time
interaction in the microarray analysis and related to relevant
immune-related pathways was studied by reverse transcription
quantitative real-time PCR (qPCR). The qPCR primer sequences,
annealing temperature (Tm) and size of amplicon are given in
Table S4. The sequences were obtained either by literature
searches or designed from EST sequences corresponding to
microarray clones or candidate genes of interest using Primer3
software (http://biotools.umassmed.edu/bioapps/primer3_www.
cgi). In addition, amplification of three potential reference genes,
cofilin-2, elongation factor-1a (elf-1a) and b-actin, was performed
but only cofilin-2 and elf-1a expression was sufficiently stable across
treatments for normalization. Cofilin-2 and elf-1a had been
identified in previous salmon cDNA microarray and qPCR studies
as suitable reference genes on the basis of constant expression
between different feeds and time points [57,58].
For qPCR, 2 mg of column-purified total RNA per sample was
reverse transcribed into cDNA using the High-Capacity cDNA RT kit
(Applied Biosystems, Paisley, U.K.), following manufacturer’s instruc-
tions, but using a mixture of the random primers (1.5 ml as supplied)
and anchored oligo-dT (0.5 ml at 400 ng/ml, Eurofins MWGOperon,
Ebersberg, Germany). Negative controls (containing no enzyme) were
performed to check for genomic DNA contamination. cDNAwas then
diluted 20-fold with water, after a similar amount of cDNAwas pooled
from all samples. qPCR analysis used relative quantification with the
amplification efficiency of the primer pairs being assessed by serial
dilutions of the cDNA pool. qPCR amplifications were carried out in
duplicate (Quantica, Techne, Cambridge, U.K.) in a final volume of
20 mL containing either 5 mL (for most genes) or 2 mL (for the
reference genes and other highly expressed genes) diluted (1/20)
cDNA, 0.5 mM of each primer and 10 mL AbsoluteTM QPCR
SYBRH Green mix (ABgene). Amplifications were carried out with a
systematic negative control (NTC-non template control, containing no
cDNA). The qPCR profiles contained an initial activation step at 95uC
for 15 min, followed by 30 to 40 cycles: 15 s at 95uC, 15 s at the
specific primer pair annealing Tm and 15 s at 72uC. After the
amplification phase, a melt curve of 0.5uC increments from 75uC to
90uC was performed, enabling confirmation of amplification of single
products, and sizes were checked by agarose gel electrophoresis and
identities confirmed by sequencing. Non-occurrence of primer-dimer
formation in the NTC was also verified. Data were analyzed using the
relative expression software tool [REST 2009, http://www.gene-
quantification.info/], which employs a pair wise fixed reallocation
randomization test (10,000 randomizations) with efficiency correction,
to determine the statistical significance of expression ratios (or gene
expression fold-changes) between two treatments [59].
Assessment of viral load
Relative quantification of ASRV by qPCR was used to
determine differences in the viral load between the different
dietary treatments at the two critical points in the time-course of
the infection (12- and 16- weeks post-challenge) when differential
expression of genes related to the inflammatory process was
greatest between fish fed the ST diet and fish fed the functional
feeds. The qPCR primer sequences (Table S4) previously
described by Mikalsen et al. [3] were employed following the
same procedure and from the same RNA samples used for the
validation of the microarray (as described above).
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Supporting Information
Figure S1 Normalized gene expression levels in heart for
different gene groups. The genes listed in Tables 4–9 are included
in figures A–F, showing the average gene expression levels (as
whiskers), with maximum and minimum range for each gene
group. Outliers are depicted as black dots. A) Viral infection-
related genes; B) Innate immune system-related genes; C) IFN I
related-genes; D) Antiviral host responses related-genes; E) IFN II-
related genes; and F) Adaptive immune system related-genes. P
values are depicted (One-way Anova) and n is the same as in
corresponding Tables 4–9.
(TIF)
Table S1 Complete list of the down-regulated genes at 12wpc on
the group of fish fed with the ST diet and 16wpc on the group of
fish fed with the FF2 diet from cluster groups (identified by SOM).
(XLSX)
Table S2 Complete list of the down-regulated genes at 12wpc on
the group of fish fed with the ST diet and 16wpc on the group of
fish fed with the FF2 diet from cluster groups (identified by SOM).
(XLSX)
Table S3 Criteria used to score the histological changes in the
heart (epicard, ventricle and atrium).
(DOCX)
Table S4 Primers used for RT-qPCR analyses.
(DOCX)
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